Macrophage migration inhibitory factor as a potential novel biomarker for cognitive function in patients with first-episode schizophrenia

CONCLUSION: Macrophage migration inhibitory factor may be involved in the process of cognitive impairment in first-episode schizophrenia and repair mechanisms following risperidone treatment.PMID:33985351 | DOI:10.1177/00048674211013086

Source: The Australian and New Zealand Journal of Psychiatry - May 14, 2021 Category: Psychiatry Authors: Jian-Jin Yu Qing Zhao Hong-Na Li Jia-Qi Song Da-Chun Chen Source Type: research